[go: up one dir, main page]

NO20083270L - indole compounds - Google Patents

indole compounds

Info

Publication number
NO20083270L
NO20083270L NO20083270A NO20083270A NO20083270L NO 20083270 L NO20083270 L NO 20083270L NO 20083270 A NO20083270 A NO 20083270A NO 20083270 A NO20083270 A NO 20083270A NO 20083270 L NO20083270 L NO 20083270L
Authority
NO
Norway
Prior art keywords
indole compounds
indole
compounds
Prior art date
Application number
NO20083270A
Other languages
Norwegian (no)
Inventor
Rolf Kristian Berge
Andrew David Miller
Michael R Jorgensen
Jon Skorve
Therese Rost
Yushma Bhurruth-Alcor
Original Assignee
Thia Medica As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica As filed Critical Thia Medica As
Priority to NO20083270A priority Critical patent/NO20083270L/en
Priority to PCT/NO2009/000270 priority patent/WO2010011147A1/en
Publication of NO20083270L publication Critical patent/NO20083270L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20083270A 2008-07-23 2008-07-23 indole compounds NO20083270L (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
NO20083270A NO20083270L (en) 2008-07-23 2008-07-23 indole compounds
PCT/NO2009/000270 WO2010011147A1 (en) 2008-07-23 2009-07-23 Indole compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20083270A NO20083270L (en) 2008-07-23 2008-07-23 indole compounds

Publications (1)

Publication Number Publication Date
NO20083270L true NO20083270L (en) 2010-01-25

Family

ID=41202538

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20083270A NO20083270L (en) 2008-07-23 2008-07-23 indole compounds

Country Status (2)

Country Link
NO (1) NO20083270L (en)
WO (1) WO2010011147A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR083953A1 (en) 2010-11-22 2013-04-10 Array Biopharma Inc COMPOUNDS TO TREAT NEURODEGENERATIVE DISEASES

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU749505B2 (en) * 1997-10-27 2002-06-27 Dr. Reddy's Laboratories Limited Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
JP4286782B2 (en) * 2002-09-12 2009-07-01 エフ．ホフマン−ラ ロシュ アーゲー N-substituted-1H-indole-5-propionic acid compounds as PPAR agonists useful for the treatment of diabetes

Also Published As

Publication number Publication date
WO2010011147A1 (en) 2010-01-28

Similar Documents

Publication Publication Date Title
DK2288375T3 (en) PEGYLED INSULIN-LISPRO COMPOUNDS
BRPI0920707A2 (en) compounds
DK2242759T3 (en) compounds
DK2340021T3 (en) SUBSTITUTED PYRROLIDIN-2-CARBOXAMIDES
BRPI0914942A2 (en) Oxindole Compounds
BRPI0907376A2 (en) Photobiorretador
DK2308877T3 (en) Imidazopyridine-2-one derivatives
BRPI0914649A2 (en) Piprazole-quinazolines
SMT201600045B (en) C7-FLUORO REPLACED TETRACYCLINIC COMPOUNDS
DE602008003521D1 (en) Sitzrücklehnungsmechanismus
FIC20240018I1 (en) My vamoro
BRPI0906705A2 (en) Heterocyclic Compounds
DK2297162T3 (en) compounds
DK2275414T3 (en) CYCLOPENTYLACRYLAMIDE DERIVATIVES
ATE545635T1 (en) SUBSTITUTED N-OXIDEPYRAZINE DERIVATIVES
BRPI0922098A2 (en) inorganic compounds
BRPI0916432A2 (en) compounds
BRPI0915562A2 (en) tamis improved
BRPI0907522A2 (en) biarlamides
BRPI0915442A2 (en) tamis improved
HRP20150932T1 (en) HETEROCYCLIC COMPOUNDS
DE112009000183A5 (en) Sicherheitsvorreiber
BRPI0923592A2 (en) compound
ATE534634T1 (en) 2-PHENYL-4-CYCLOPROPYL-PYRIMIDINE DERIVATIVES
BRPI0909634A2 (en) 2-aminoquinolines

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application